Compounding World News

From APC: https://a4pc.org/news/the-gray-market-just-got-a-little-less-gray-in-mississippi Getting a nursing board, a pharmacy board, and a medical board to agree on lunch is hard enough, so getting all three to sign the same regulatory statement is significant. That’s what happened in Mississippi this week, when the state’s Board of Nursing, Board of Pharmacy, and State Board of Medical Licensure jointly declared that research-grade peptides are off the table for healthcare

FDA moves to exclude three GLP-1s from 503B compounding

News Article from Reuters: US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs

Statement from the Alliance for Pharmacy Compounding on FDA Proposed Rule Regarding 503B Bulks List

FDA’s Pep(tide) Rally! What Compounders and Industry Need to Know (Post 2 of 2)

FDA’s Pep(tide) Rally! What Compounders and Industry Need to Know (Post 1 of 2)

Scott Bruner and Joe Navarra Spoke at PCCA's ThinkNext even in Houston, joined by PCCA CEO Gus Bassani and NCPA CEO Doug Hoey.